153 related articles for article (PubMed ID: 17483959)
1. Performance of the beryllium blood lymphocyte proliferation test based on a long-term occupational surveillance program.
Donovan EP; Kolanz ME; Galbraith DA; Chapman PS; Paustenbach DJ
Int Arch Occup Environ Health; 2007 Nov; 81(2):165-78. PubMed ID: 17483959
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the beryllium lymphocyte proliferation test using statistical process control.
Cher DJ; Deubner DC; Kelsh MA; Chapman PS; Ray RM
Inhal Toxicol; 2006 Oct; 18(11):901-10. PubMed ID: 16864408
[TBL] [Abstract][Full Text] [Related]
3. Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant.
Henneberger PK; Cumro D; Deubner DD; Kent MS; McCawley M; Kreiss K
Int Arch Occup Environ Health; 2001 Apr; 74(3):167-76. PubMed ID: 11355290
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of serial medical surveillance for chronic beryllium disease in a beryllium machining plant.
Newman LS; Mroz MM; Maier LA; Daniloff EM; Balkissoon R
J Occup Environ Med; 2001 Mar; 43(3):231-7. PubMed ID: 11285871
[TBL] [Abstract][Full Text] [Related]
5. Cumulative sensitization and disease in a beryllium oxide ceramics worker cohort.
Schuler CR; Kitt MM; Henneberger PK; Deubner DC; Kreiss K
J Occup Environ Med; 2008 Dec; 50(12):1343-50. PubMed ID: 19092488
[TBL] [Abstract][Full Text] [Related]
6. Beryllium sensitization in aluminum smelter workers.
Taiwo OA; Slade MD; Cantley LF; Fiellin MG; Wesdock JC; Bayer FJ; Cullen MR
J Occup Environ Med; 2008 Feb; 50(2):157-62. PubMed ID: 18301172
[TBL] [Abstract][Full Text] [Related]
7. Enhanced preventive programme at a beryllium oxide ceramics facility reduces beryllium sensitisation among new workers.
Cummings KJ; Deubner DC; Day GA; Henneberger PK; Kitt MM; Kent MS; Kreiss K; Schuler CR
Occup Environ Med; 2007 Feb; 64(2):134-40. PubMed ID: 17043076
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of a program to prevent beryllium sensitization among new employees at a copper-beryllium alloy processing facility.
Thomas CA; Bailey RL; Kent MS; Deubner DC; Kreiss K; Schuler CR
Public Health Rep; 2009; 124 Suppl 1(Suppl 1):112-24. PubMed ID: 19618813
[TBL] [Abstract][Full Text] [Related]
9. Machining risk of beryllium disease and sensitization with median exposures below 2 micrograms/m3.
Kreiss K; Mroz MM; Newman LS; Martyny J; Zhen B
Am J Ind Med; 1996 Jul; 30(1):16-25. PubMed ID: 8837677
[TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy of a program to prevent beryllium disease.
Thomas CA; Deubner DC; Stanton ML; Kreiss K; Schuler CR
Am J Ind Med; 2013 Jul; 56(7):733-41. PubMed ID: 23450749
[TBL] [Abstract][Full Text] [Related]
11. Sensitization and chronic beryllium disease among workers in copper-beryllium distribution centers.
Stanton ML; Henneberger PK; Kent MS; Deubner DC; Kreiss K; Schuler CR
J Occup Environ Med; 2006 Feb; 48(2):204-11. PubMed ID: 16474270
[TBL] [Abstract][Full Text] [Related]
12. Beryllium sensitivity among workers at a Norwegian aluminum smelter.
Nilsen AM; Vik R; Behrens C; Drabløs PA; Espevik T
Am J Ind Med; 2010 Jul; 53(7):724-32. PubMed ID: 20187010
[TBL] [Abstract][Full Text] [Related]
13. Industries in the United States with airborne beryllium exposure and estimates of the number of current workers potentially exposed.
Henneberger PK; Goe SK; Miller WE; Doney B; Groce DW
J Occup Environ Hyg; 2004 Oct; 1(10):648-59. PubMed ID: 15631056
[TBL] [Abstract][Full Text] [Related]
14. Beryllium sensitization, chronic beryllium disease, and exposures at a beryllium mining and extraction facility.
Deubner D; Kelsh M; Shum M; Maier L; Kent M; Lau E
Appl Occup Environ Hyg; 2001 May; 16(5):579-92. PubMed ID: 11370937
[TBL] [Abstract][Full Text] [Related]
15. Is total mass or mass of alveolar-deposited airborne particles of beryllium a better predictor of the prevalence of disease? A preliminary study of a beryllium processing facility.
Kent MS; Robins TG; Madl AK
Appl Occup Environ Hyg; 2001 May; 16(5):539-58. PubMed ID: 11370934
[TBL] [Abstract][Full Text] [Related]
16. Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations.
Kreiss K; Wasserman S; Mroz MM; Newman LS
J Occup Med; 1993 Mar; 35(3):267-74. PubMed ID: 8455096
[TBL] [Abstract][Full Text] [Related]
17. The beryllium lymphocyte proliferation test: Relevant issues in beryllium health surveillance.
Stange AW; Furman FJ; Hilmas DE
Am J Ind Med; 2004 Nov; 46(5):453-62. PubMed ID: 15490468
[TBL] [Abstract][Full Text] [Related]
18. The beryllium bronchoalveolar lavage lymphocyte proliferation test: indicator of beryllium sensitization, inflammation or both?
Heldt GH; Deubner DC
Inhal Toxicol; 2015; 27(5):262-71. PubMed ID: 25942054
[TBL] [Abstract][Full Text] [Related]
19. Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility.
Schuler CR; Kent MS; Deubner DC; Berakis MT; McCawley M; Henneberger PK; Rossman MD; Kreiss K
Am J Ind Med; 2005 Mar; 47(3):195-205. PubMed ID: 15712254
[TBL] [Abstract][Full Text] [Related]
20. Exposure-response analysis for beryllium sensitization and chronic beryllium disease among workers in a beryllium metal machining plant.
Madl AK; Unice K; Brown JL; Kolanz ME; Kent MS
J Occup Environ Hyg; 2007 Jun; 4(6):448-66. PubMed ID: 17474035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
